Blackstone Inc (NYSE:BX) has been identified as one of the best NYSE stocks to buy for the long term. Recently, the company led a $10 billion debt investment in the Australian AI infrastructure company Firmus, as reported by Reuters on February 9. This strategic move is expected to fuel Firmus’ Project Southgate, which aims to meet the growing demand for high-performance computing through the national rollout of an AI Factory platform.
In addition to this significant investment, Chinese regulators have given their approval for Blackstone’s deal to acquire Hologic (HOLX), a leading specialist in women’s health diagnosis. Teaming up with TPG, Blackstone is poised to make a substantial impact in the women’s healthcare space with this acquisition.
However, Piper Sandler strategists recently reiterated a Neutral rating on BX stock, citing tepid 2026 guidance compared to market expectations. As a result, they have lowered their 2026 and 2027 EPS estimates for Blackstone. Despite this setback, Blackstone Inc remains the world’s largest alternative asset manager with over $1 trillion in assets under management, serving both institutional and individual investors.
While Blackstone presents investment potential, some AI stocks may offer greater upside potential with less downside risk. For investors seeking undervalued AI stocks that could benefit from Trump-era tariffs and the onshoring trend, exploring alternative options may be worthwhile. A free report on the best short-term AI stock could provide valuable insights for those looking to diversify their investment portfolio.
For more investment opportunities, readers can explore the 10 Best Medical Technology Stocks to Invest In and the 12 Best Foreign Stocks to Buy Right Now. As always, it is important to conduct thorough research and seek professional advice before making any investment decisions.
Disclosure: None. This article was originally published on Insider Monkey.
